Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Jan 12, 2020 7:45pm

161 Views

Post# 30544692

RE:RE:RE:RE:RE:Heffalump and/or Woozle in the Room

goldn1 wrote:
Far from negative, just realistic... Assuming every patient enrolled is cancer free after 90 days is irresponsible... I want TLT to work, just think we need more data to make statement like that...

All patients achieved both primary and secondary endpoints at 90 days. Not irresponsible, i am just able to read and comprehend. The exact same will happen in phase 2, I am telling you the 6 Month data will be pivotal for this trial and if we achieve high CR (and TLT is able to share the results) you can double down on your investment and sleep easy..
Macer

Bullboard Posts

Visionstate set to leverage success in the U.S. market